MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in RPRX — Royalty Pharma plc

CIK 1705339 CAUSEWAY BAY, K3

Position in RPRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$14,543,997

-$5,561,620 QoQ

Shares Held

259,390

-38.1% QoQ

Ownership

0.045%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#127

of 646 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $446,316,962 across 286 Biotechnology names. RPRX ranks #4 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	150,692	$74,853,236
2	REGN	Regeneron Pharmaceuticals, Inc.	59,595	$37,159,864
3	ALNY	Alnylam Pharmaceuticals, Inc.	63,265	$19,044,662
4	RPRX	Royalty Pharma plc This page	259,390	$14,543,997
5	TWST	Twist Bioscience Corp	100,108	$10,299,110
6	INCY	Incyte Corp	83,084	$9,418,401
7	PRAX	Praxis Precision Medicines, Inc.	27,185	$9,101,265
8	MRNA	Moderna, Inc.	106,564	$7,462,676

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,543,997	259,390	-38.1%	Shares	Defined	2026-08-14
2026-03-31	$20,105,617	419,129	+2.3%	Shares	Defined	2026-05-15
2025-12-31	$15,830,652	409,696	+56.8%	Shares	Defined	2026-02-17
2025-09-30	$9,218,451	261,294	+1591.3%	Shares	Defined	2025-11-14
2025-06-30	$556,626	15,449	-80.7%	Shares	Defined	2025-08-14
2025-03-31	$2,490,088	79,990	+20.3%	Shares	Defined	2025-05-15
2024-12-31	$1,696,440	66,501	+25.2%	Shares	Defined	2025-02-14
2024-09-30	$1,502,906	53,125	+10.2%	Shares	Defined	2024-11-14
2024-06-30	$1,270,770	48,190	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.